Abstract:BACKGROUND: Cluster of differentiation 8 (CD8 T) cells play critical roles in eradicating human immunodeficiency virus (HIV)-1 infection, but little is known about the effects of T cells expressing CD8 at low levels (CD8 low ) or high levels (CD8 high ) on HIV-1 replication inhibition after HIV-1 invasion into individual.METHODS: Nineteen patients who had been acutely infected with HIV-1 (AHI) and 20 patients with chronic infection (CHI) for ≥2 years were enrolled in this study to investigate the dynamics of the quantity, activation, and immune responses of CD3 + CD8 low T cells and their counterpart CD3 + CD8 high T cells at different stages of HIV-1 infection.RESULTS: Compared with healthy donors, CD3 + CD8 low T cells expanded in HIV-1-infected individuals at different stages of infection. As HIV-1 infection progressed, CD3 + CD8 low T cells gradually decreased. Simultaneously, CD3 + CD8 high T cells was significantly reduced in the first month of AHI and then increased gradually as HIV-1 infection progressed. The classical activation of CD3 + CD8 low T cells was highest in the first month of AHI and then reduced as HIV-1 infection progressed and entered the chronic stage. Meanwhile, activated CD38 - HLA-DR + CD8 low T cells did not increase in the first month of AHI, and the number of these cells was inversely associated with viral load ( r = -0.664, P = 0.004) but positively associated with the CD4 T-cell count ( r = 0.586, P = 0.014). Increased programmed cell death protein 1 (PD-1) abundance on CD3 + CD8 low T cells was observed from the 1st month of AHI but did not continue to be enhanced, while a significant T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (TIGIT) abundance increase was observed in the 12th month of infection. Furthermore, increased PD-1 and TIGIT abundance on CD3 + CD8 low T cells was associated with a low CD4 T-cell count (PD-1: r = -0.456, P = 0.043; TIGIT: r = -0.488, P = 0.029) in CHI. Nonetheless, the nonincrease in PD-1 expression on classically activated CD3 + CD8 low T cells was inversely associated with HIV-1 viremia in the first month of AHI ( r = -0.578, P = 0.015). Notably, in the first month of AHI, few CD3 + CD8 low T cells, but comparable amounts of CD3 + CD8 high T cells, responded to Gag peptides. Then, weaker HIV-1-specific T-cell responses were induced in CD3 + CD8 low T cells than CD3 + CD8 high T cells at the 3rd and 12th months of AHI and in CHI.CONCLUSIONS: Our findings suggest that CD3 + CD8 low T cells play an anti-HIV role in the first month of infection due to their abundance but induce a weak HIV-1-specific immune response. Subsequently, CD3 + CD8 low T-cell number decreased gradually as infection persisted, and their anti-HIV functions were inferior to those of CD3 + CD8 high T cells.

Plasmacytoid Dendritic Cells Prime Antiviral T Cells During Acute Hiv-1 Infection But Deplete And Impair Anti-Viral T Cells During Chronic Hiv-1 Infection

Plasmacytoid Dendritic Cells Suppress Hiv-1 Replication but Contribute to Hiv-1 Induced Immunopathogenesis in Humanized Mice

Plasmacytoid Dendritic Cells Impair HIV-specific CD8 T Cells to Maintain HIV-1 Reservoir Persistence During Chronic HIV Infection under Cart

Advance in roles of plasmacytoid dendritic cells in viral infection immunity

Plasmacytoid Dendritic Cells Contribute to HIV Diseases and Viral Persistence Via IDO-dependent Mechanisms

Plasmacytoid Dendritic Cells Impair Anti-HIV Immunity and HIV-1 Persistence During Antiretroviral Therapy Via IDO-Dependent Mechanisms

HIV-1 Infection Depletes Human CD34+CD38- Hematopoietic Progenitor Cells Via Pdc-Dependent Mechanisms

Chronic Hiv-1 Infection Induces the Depletion and Functional Impairment of Group-3 Innate Lymphoid Cells Through Plasmacytoid Dendritic Cells and Type I Interferon

Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1

Inhibitory Effects of Human Immunodeficiency Virus Gp120 and Tat on Cpg-A-Induced Inflammatory Cytokines in Plasmacytoid Dendritic Cells

Infection and Depletion of CD4+ Group-1 Innate Lymphoid Cells by HIV-1 Via Type-I Interferon Pathway.

B7-H1 Up-Regulation Impairs Myeloid Dc and Correlates with Disease Progression in Chronic Hiv-1 Infection

Magnitude of Type I Interferon Responses by Plasmacytoid Dendritic Cells After TLR7 Stimulation Is Associated With Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir Sizes in Cisgender Women With HIV-1 on Antiretroviral Therapy

Type I Interferons Suppress Viral Replication but Contribute to T Cell Depletion and Dysfunction During Chronic HIV-1 Infection

Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-β pathways

Dendritic Cell Dysfunction During Primary Hiv-1 Infection

The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond

Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals

The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease.

Changing roles of CD3+CD8low T cells in combating HIV-1 infection

The Potential Role of CD16(+) V gamma 2V delta 2 T Cell-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity in Control of HIV Type 1 Disease